维普中文期刊产品整合服务
47篇 您的检索式:作者名="Cakaloglu"
    题名 作者 年代 出处 被引量
12-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B显示文摘Yun–Fan Liaw Edward Gane Nancy Leung Stefan Zeuzem Yuming Wang Ching Lung Lai E. Jenny Heathcote Michael Manns Natalie Bzowej Junqi Niu Steven–Huy Han Seong Gyu Hwang Yilmaz Cakaloglu Myron J. Tong George Papatheodoridis Yagang Chen Nathaniel A. Brown Efs 2009Gastroenterology2009,,2:13
2Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B显示文摘Milan J. Sonneveld Vincent W.–S. Wong Andrea M. Woltman Grace L.H. Wong Yilmaz Cakaloglu Stefan Zeuzem Erik H.C.J. Buster Andre G. Uitterlinden Bettina E. Hansen Henry L.Y. Chan Harry L.A. Janssen 2012Gastroenterology2012,,3:3
3Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial显示文摘Harry LA Janssen Monika van Zonneveld Hakan Senturk Stefan Zeuzem Ulus S Akarca Yilmaz Cakaloglu Christopher Simon Thomas MK So Guido Gerken Robert A de Man Hubert GM Niesters Pieter Zondervan Bettina Hansen Solko W Schalm 2005The Lancet . 2005 (9454)2005,,:2
4Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with pegintefferon alpha-2b显示文摘Buster EH Flink HJ Cakaloglu Y 2008Gastroenterology2008,135,2:1
5Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitisB using HBsAg and HBV DNA levels 显示文摘Rijckborst V Hansen BE Cakaloglu Y Ferenci P Tabak F Akdogan M Simon K Akarca US Flisiak R Verhey E Van Vuuren AJ Boucher CA ter Borg MJ Janssen HL 2010Hepatology2010,52,2:1
6Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial显示文摘Harry LA Janssen Monika van Zonneveld Hakan Senturk Stefan Zeuzem Ulus S Akarca Yilmaz Cakaloglu Christopher Simon Thomas MK So Guido Gerken Robert A de Man Hubert GM Niesters Pieter Zondervan Bettina Hansen Solko W Schalm 20052005 (9454)2005,,9454:1
7Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b显示文摘Erik H.C.J. Buster Hajo J. Flink Yilmaz Cakaloglu Krzysztof Simon J?rg Trojan Fehmi Tabak Thomas M.K. So S. Victor Feinman Tomasz Mach Ulus S. Akarca Martin Schutten Wanda Tielemans Anneke J. van Vuuren Bettina E. Hansen Harry L.A. Janssen 2008Gastroenterology2008,,2:1
8Durable hepatitis B surface antigen deeline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype 显示文摘Sonneveld M J Rijckborst V Cakaloglu Y 2012Antivir Ther2012,17,1:1
9Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with pegintefferon alpha-2b 显示文摘Buster EH Flink H J Cakaloglu Y 2008Gastroenterology2008,135,2:1
102-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B显示文摘Yun–Fan Liaw Edward Gane Nancy Leung Stefan Zeuzem Yuming Wang Ching Lung Lai E. Jenny Heathcote Michael Manns Natalie Bzowej Junqi Niu Steven–Huy Han Seong Gyu Hwang Yilmaz Cakaloglu Myron J. Tong George Papatheodoridis Yagang Chen Nathaniel A. Brown Efs 2009Gastroenterology2009,,2:1
11Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b显示文摘Buster EH Flink HJ Cakaloglu Y 2008Gastroenterology2008,135,:1
12Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels 显示文摘Rijckborst V Hansen BE Cakaloglu Y Ferenci P Tabak F Akdogan M Simon K Akarca US Flisiak R Verhey E Van Vuuren AJ Boucher CA ter Borg MJ Janssen HL 2010Hepatology2010,52,2:1
13Sustained HBeAg and HBsAg loss after long-term follow -up of HBeAg positive patients treated with peginterfern alpha- 2b 显示文摘Buster E H Flink H J Cakaloglu Y 2008Gastroenterology2008,135,2:1
14Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b显示文摘Erik H.C.J. Buster Hajo J. Flink Yilmaz Cakaloglu Krzysztof Simon J?rg Trojan Fehmi Tabak Thomas M.K. So S. Victor Feinman Tomasz Mach Ulus S. Akarca Martin Schutten Wanda Tielemans Anneke J. van Vuuren Bettina E. Hansen Harry L.A. Janssen 2008Gastroenterology2008,,2:1
15Early on-treat-ment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels显示文摘Rijckborst V Hansen BE Cakaloglu Y 0,,02:1
16Early on - treatment prediction of response to peginterferon alfa - 2a for HBeAg- negative chronic hepatitis B using HBsAg and HBV DNA levels 显示文摘Rijckborst V Hansen BE Cakaloglu Y 2010Hepatology2010,,2:1
17Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial显示文摘Harry LA Janssen Monika van Zonneveld Hakan Senturk Stefan Zeuzem Ulus S Akarca Yilmaz Cakaloglu Christopher Simon Thomas MK So Guido Gerken Robert A de Man Hubert GM Niesters Pieter Zondervan Bettina Hansen Solko W Schalm 2005The Lancet2005,,9454:1
18Early on-treatment prediction of response to peginterferon alfa-2a for HBeAgnegative chronic hepatitis B using HBsAg and HBV DNA levels 显示文摘Rijckborst V Hansen BE Cakaloglu Y 2010Hepatology2010,52,2:1
19Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon al- pha-2b显示文摘Buster EH Flink H J Cakaloglu Y 2008Gastroenterology2008,135,2:1
20Importance of concomitant viral infection during late,, acute, liver allograft rejection 显示文摘Cakaloglu Y Devlin J O'Grady 1995Transplantion1995,59,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费